KIR2DL3 and type 1 diabetes mellitus: Early studies reported reduced cytotoxicity of peripheral blood NK cells in patients with T1D, which correlated with decreased numbers of NKG2D+ NK cells and increased numbers of KIR2DL3+ and NKG2A+ NK cells (71).